Summary

In this role, you will help shape the global commercial strategy for an investigational therapy in acute ischemic stroke, a high-burden condition with significant unmet need and limited treatment options for many patients. You will play a key role during proof-of-concept development, guiding strategic choices that inform the target product profile and potential later-stage clinical development. This is not a conventional marketing role focused on campaigns or promotional materials. You will bring a broad commercial and program perspective to complex scientific, clinical, access, manufacturing, and market questions. Working with a global cross-functional team, you will evaluate potential scenarios, clarify decision points, and anticipate how the rapidly evolving treatment landscape may affect the program. Your work will contribute to evidence-based investment decisions, future commercialization planning, and preparation for hospital-based adoption if proof of concept is achieved.

Job description

About the Role

In this role, you will help shape the global commercial strategy for an investigational therapy in acute ischemic stroke, a high-burden condition with significant unmet need and limited treatment options for many patients. You will play a key role during proof-of-concept development, guiding strategic choices that inform the target product profile and potential later-stage clinical development. This is not a conventional marketing role focused on campaigns or promotional materials. You will bring a broad commercial and program perspective to complex scientific, clinical, access, manufacturing, and market questions. Working with a global cross-functional team, you will evaluate potential scenarios, clarify decision points, and anticipate how the rapidly evolving treatment landscape may affect the program. Your work will contribute to evidence-based investment decisions, future commercialization planning, and preparation for hospital-based adoption if proof of concept is achieved.

How You Will Contribute

Lead commercial scenario planning by evaluating clinical outcomes, competitor developments, treatment changes, regulatory pathways, and potential commercialization options.
Shape clinical development strategy by connecting endpoints, evidence requirements, patient needs, access considerations, and potential pricing implications.
Refine the target product profile through market research, stakeholder insights, forecasting, and assessment of future treatment scenarios.
Establish strategic decision frameworks that clarify available options, key assumptions, decision triggers, and recommendations for program investment.
Guide cross-functional collaboration across clinical development, access, insights, manufacturing, medical, regulatory, and regional teams.
Develop positioning and market strategy for potential standalone or combination use within a complex scientific-based treatment pathway.
Engage scientific and senior stakeholders to test strategic options, communicate recommendations, and support informed decision-making.

Qualifications

University degree in marketing, business, life sciences, or a related field.
At least 10 years of experience in the pharmaceutical industry.
Experience supporting a product launch, pre-launch program, or late-stage clinical development program.
Demonstrated ability to develop scenarios, evaluate assumptions, and translate complex scientific and market information into clear strategic recommendations.
Experience translating strategy into execution through insight generation, partner management, budget and timeline ownership, and delivery of critical assets.
Ability to understand complex scientific evidence and communicate effectively with scientific experts, cross-functional partners, and senior leaders.
Strong business judgment, communication, influencing, stakeholder management, and information-processing skills.
Demonstrated ability to lead globally across functions, work independently, manage uncertainty, and deliver outcomes with minimal direction.

Requirements

University degree in marketing, business, life sciences, or a related field.
At least 10 years of experience in the pharmaceutical industry.
Experience supporting a product launch, pre-launch program, or late-stage clinical development program.
Demonstrated ability to develop scenarios, evaluate assumptions, and translate complex scientific and market information into clear strategic recommendations.
Experience translating strategy into execution through insight generation, partner management, budget and timeline ownership, and delivery of critical assets.
Ability to understand complex scientific evidence and communicate effectively with scientific experts, cross-functional partners, and senior leaders.
Strong business judgment, communication, influencing, stakeholder management, and information-processing skills.
Demonstrated ability to lead globally across functions, work independently, manage uncertainty, and deliver outcomes with minimal direction.

Benefits

Medical, Dental & Vision
401(k) Matching
Paid Time Off

Company overview

Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company founded in 1781 and incorporated in 1925. As one of the world's top 20 largest pharmaceutical companies by revenue and the third largest in Asia, Takeda specializes in developing and commercializing innovative medicines across several therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. With approximately 49,095 employees globally, the company operates research and development centers, manufacturing facilities, and commercial operations across 39 U.S. states and numerous countries worldwide. Takeda maintains dual headquarters in Tokyo and Osaka, Japan, with significant operations in Cambridge, Massachusetts, where it serves as the largest life sciences employer in the state. The company's patient-focused approach is guided by its Takeda-ism values of Integrity, Fairness, Honesty, and Perseverance, emphasizing a commitment to delivering life-transforming treatments while advancing sustainable healthcare solutions. Takeda's extensive portfolio includes both innovative biologics and small molecule drugs, supported by strategic acquisitions and partnerships that have expanded its capabilities in areas such as immuno-oncology and rare disease treatments.